Trial Profile
A retrospective trial to evaluate vemurafenib as treatment for BRAF-Mutant melanoma and brain metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 17 May 2016 New trial record